The combination of type 2 diabetes and chronic kidney disease markedly increases mortality.
Metabolic and cardiac disease both accelerate chronic kidney disease, and all three together accelerate cardiovascular hospitalizations and death.
Patients struggle to find individual experts to manage each disease domain let alone anyone who can take a holistic approach to multiple complex conditions.
Fewer than one third of patients are on evidence-based therapies for CKM at the target doses.
SDOH must be assessed to correctly estimate risk and addressed to reduce it.
Onboarding is rapid and Atman’s technology and our care team fully integrate remote care to create a personal trajectory that ensures the right care is delivered at the right time in the right place.
Our fully systematized approach to diagnosis and management seamlessly incorporates every detail about you into each decision. We manage guideline-directed medical therapy in kidney and cardiac conditions as well as type 2 diabetes and obesity.
Our care navigators, who work closely with the physician on the same software platform, are attentive and empathic guides who help you attain your individually tailored goals.
The Atman software ensures that the latest evidence shapes every decision, no detail is missed, and maximizes the impact of emerging technologies on outcomes.
We partner with providers and/or payers as a remote service provider to manage select disease conditions in targeted patient populations
We work with our partners to screen and enroll patients into our remote management programs
Once enrolled, we engage with the patients directly and conduct initial program setup, including appropriate devices provisioning and data intake
After collection of all the information, our platform helps determine patient specific goals for given conditions
Next, we identify personalized treatment plans considering all patient specific information, including currently administered medications, known co-morbidities and preferences
Our remote team then works with the patients to determine optimal medications and titrations by rapid monitoring of drug response
Once optimal goals are reached our team will continue to engage with the patients and monitor/optimize deviations from the goals